「usp」の検索結果

Builds, runs, debugs, and operates applications on AWS Lambda MicroVMs — Firecracker-isolated, snapshot-resumable serverless compute environments running inside a container with up to 8 hr lifetimes. Applicable when workloads need strong isolation between tenants, isolated serverless compute, sandbox compute, or secure multi-tenant execution. Also suited for AI/agent code-execution sandboxes, interactive code playgrounds and notebooks (Jupyter, REPLs, dev environments running user-supplied code), reinforcement-learning environments, multi-tenant CI executors and build runners, sessionful game or simulation servers, or isolated security scanners. Also applicable when the workload needs long-lived sessions, a real port-listening server (gRPC, WebSocket, custom TCP protocols), state preserved across periods of inactivity (suspend/resume), container-level access (FUSE, eBPF, custom syscalls), or session-affine routing.

日本語の概要は準備中です。原文の説明を表示しています。

Cross-validate CLI flags, docs, tests, and targets for consistency across the codebase. Use this skill whenever the user asks to: audit the codebase, check for consistency issues, find undocumented flags, verify test coverage, validate targets.yaml, check handler split conventions, or verify oplog instrumentation. This is a read-only audit — it reports issues but never modifies files. Use after large refactors, before releases, or whenever you suspect docs/code/tests have drifted out of sync.

日本語の概要は準備中です。原文の説明を表示しています。

React 19 patterns including Server Components, Actions, Suspense, hooks, and component composition

日本語の概要は準備中です。原文の説明を表示しています。

Build a complete marketing plan covering the full customer journey from stranger to raving fan. Use when the user mentions "marketing plan", "marketing strategy", "target market", "USP", "lead nurture", "customer lifetime value", "PVP Index", or "I dont know where to start with marketing". Also trigger when building a marketing plan from scratch, choosing acquisition channels, or designing end-to-end customer-lifecycle campaigns. Covers the PVP Index, channel selection, and advocacy systems. For brand messaging, see storybrand-messaging. For conversion optimization, see cro-methodology.

日本語の概要は準備中です。原文の説明を表示しています。

When the user's app or update was rejected by Apple App Review or Google Play Review and they need to diagnose why, fix it, and resubmit fast. Use when the user mentions "app rejected", "App Review rejection", "guideline violation", "Apple rejected my app", "Google Play rejected", "Play policy violation", "Resolution Center", "metadata rejection", "binary rejection", "guideline 2.1", "guideline 4.3", "guideline 5.1.1", "Sign in with Apple required", "Apple ID rejection", "Play Store suspension", "appeal", "I need to respond to App Review", or "expedited review". For pre-submission listing health, see aso-audit. For metadata-only fixes, see metadata-optimization.

日本語の概要は準備中です。原文の説明を表示しています。

Runs a security incident from detection to closure — triage, containment, investigation, communication, and the review afterward. Use this when a compromise is suspected or confirmed, when preparing an incident response plan or running an exercise, when deciding whether something is an incident, or when a breach may trigger notification obligations.

日本語の概要は準備中です。原文の説明を表示しています。

Handles a dispute from the first sign of it — recognizing when preservation obligations attach, issuing and scoping a legal hold, suspending automatic deletion across every system that holds relevant material, preserving privilege, managing outside counsel and cost, and evaluating settlement against the real cost of continuing. Use this to respond to a claim or demand letter, issue a hold, work out which systems the hold has to reach, or decide whether to fight.

日本語の概要は準備中です。原文の説明を表示しています。

Generates complete FAERS-style pharmacovigilance disproportionality research designs from a user-provided drug class, comparator strategy, adverse-event domain, and patient-group stratification. Always use this skill whenever a user wants to design, plan, or build a spontaneous-report safety signal study using FAERS or a similar pharmacovigilance database, especially when the article logic includes product selection, indication-group stratification, MedDRA-based adverse-event extraction, serious-case filtering, suspect-drug and concomitant-exclusion logic, reporting odds ratio analysis, comparator-drug benchmarking, cross-drug comparison, and cautious signal interpretation without causal overclaiming. Covers five study patterns (single-drug disproportionality workflow, multi-drug class comparison workflow, indication-stratified workflow, comparator-controlled signal screening workflow...

日本語の概要は準備中です。原文の説明を表示しています。

Mainland-Chinese TV-series craft, documents and production chain (国产剧创作体系与制片链) — the China layer parallel to the Japanese and Korean/French skills. Distilled from Yao Kougen 姚扣根《电视剧写作概论》(2016; series taxonomy, four Chinese script formats, the 3-minute/15-minute/episode-end suspense law, 36 situations), Zhang Wei 张巍《电视剧改编教程》(2014; five source types, sell-point migration, six case studies), Zhang Mingzhi & Song Peiyi《电视剧出品人与制片人教程》(2016; running-time rules, two-stage censorship, scene-breakdown sheet, contracts), Zhao Binbin《影视剧片段改编教程》(2016; film to stage fragment), plus official Chinese renderings of US TV terms from the translated Douglas and Blum textbooks. Use when writing or judging a 国产剧, turning a novel or IP into a 30–50 episode drama, writing a 策划书 / 分集梗概 / 人物小传, formatting a Chinese teleplay, sizing episode count and word count, checking content red lines and the 立项/备案/审查 chain, reading a Chinese screenwriter contract, or mapping US series vocabulary onto Chinese usage.

日本語の概要は準備中です。原文の説明を表示しています。

Runs adversarial due-diligence on a benchmark the user envies — a founder, KOL, company, or product whose success looks inflated — splitting marketing bubble from real signal, then mapping the validated playbook onto the user's own resources. Use for 尽调/对标/拆解 a competitor, 抄/偷师 their playbook, or suspecting 水分/泡沫 in claims. Prefer over deep-research when debunking inflated claims, not a neutral briefing.

日本語の概要は準備中です。原文の説明を表示しています。

Reconcile controlled-substance records and prepare for an inspection — the count against the register, the discrepancy investigation, the documentation an inspector asks for, and the reporting obligations a shortfall triggers. Use when asked to reconcile controlled drugs, prepare for a DEA or controlled-drug inspection, investigate a discrepancy or suspected diversion, or audit the CD register. Produces the reconciliation, the discrepancy investigation record, the inspection-readiness checklist, and the escalation and reporting decision tree. A process framework only; reporting thresholds, timelines and obligations are set by law in your jurisdiction and must be verified there.

日本語の概要は準備中です。原文の説明を表示しています。

Use when asked 写8D报告, 客户投诉8D, 质量问题8D, 客诉回复报告, 8D 怎么写, 根本原因分析报告, or write an 8D problem-solving report for a customer complaint or internal quality issue in a Chinese factory. Produces a bilingual (Chinese and English) 8D report from D0 to D8 with the problem described by 5W2H, dated containment actions and suspect-stock quantities, root cause for both occurrence and escape (流出) with 5 Why and fishbone evidence, verified corrective actions, prevention through updated PFMEA, control plan and SOP, and closure criteria, in the format customers expect.

日本語の概要は準備中です。原文の説明を表示しています。

Triage a raw bug report into something a team can act on — clean repro steps, a defensible severity/priority, environment, likely area/owner, and duplicate check. Use when asked to triage this bug, set severity and priority, is this a P1, or clean up this bug report for the backlog. Produces the normalized repro, a severity and priority with the reasoning (impact × frequency × workaround), the environment/metadata, a suspected component and owner queue, and a duplicate/related-issue check — flagging when info is missing rather than guessing.

日本語の概要は準備中です。原文の説明を表示しています。

Analyze Swift Package Manager dependencies, package plugins, module variants, and CI-oriented build overhead that slow Xcode builds. Use when a developer suspects packages, plugins, or dependency graph shape are hurting clean or incremental build performance, mentions SPM slowness, package resolution time, build plugin overhead, duplicate module builds from configuration drift, circular dependencies between modules, oversized modules needing splitting, or modularization best practices.

日本語の概要は準備中です。原文の説明を表示しています。

Assesses the quality and completeness of a genome annotation with BUSCO (conserved single-copy ortholog recovery), OMArk (proteome completeness, consistency, and contamination), CheckM2 (prokaryotic completeness/contamination), and a gene-set sanity panel (gene count, mono-exonic fraction, protein-length distribution, mRNA:gene ratio, coding density). Covers the assembly-BUSCO-vs-proteome-BUSCO diagnostic, what BUSCO-Duplicated really means, why gene count is a vanity metric, and the QC of transferred annotations. Use when judging whether an annotation is good enough to publish or submit, diagnosing a suspect annotation, or comparing annotation completeness across pipelines.

日本語の概要は準備中です。原文の説明を表示しています。

Detects and removes doublets/aggregates from flow, spectral, and mass cytometry before clustering or quantification. Covers FSC-A vs FSC-H singlet discrimination (the Area-Height non-proportionality, not a 1D area gate), FSC-W/SSC width gating, CyTOF Gaussian discrimination parameters (Center/Offset/Width/Residual/Event_length) and DNA intercalator gating, and the residual heterotypic conjugates that survive scatter gating and masquerade as double-positive populations. Use when filtering aggregates before phenotyping, choosing a doublet method for flow vs CyTOF, or diagnosing a suspicious double-positive cluster.

日本語の概要は準備中です。原文の説明を表示しています。

Assigns pathogen lineages (SARS-CoV-2 Pangolin UShER mode; Nextclade clade + QC; pango-designation alias resolution) and tracks variant frequencies over time using Nextstrain (Augur + Auspice), wastewater deconvolution (Freyja, COJAC, alcov, lineagespot), lineage-fitness modelling (multinomial logistic), and recombinant detection (3SEQ, RDP4, Bolotie). Covers Pangolin pangolin-data and Nextclade dataset version pinning (mandatory; lineage-defining mutations change with dataset), Freyja barcode forward-only date constraint, ARTIC primer scheme churn (V3/V4/V4.1/V5.3.2/Midnight) with dropout regions, and recombinant X-prefix designation lag. Use when assigning Pango lineages and Nextclade clades to viral consensus sequences, building Nextstrain Augur surveillance pipelines, deconvolving wastewater into lineage frequencies with Freyja, tracking lineage frequencies over time, handling ARTIC primer dropouts, or running surveillance for SARS-CoV-2/influenza/Mpox/RSV/H5N1/measles.

日本語の概要は準備中です。原文の説明を表示しています。

Creates DE-specific diagnostic and result visualizations using DESeq2/edgeR built-in functions and lightweight ggplot2 wrappers. Covers MA plot (with the shrunken-LFC compression effect), volcano (with the apeglm caveat that p-values are unchanged), PCA on VST/rlog (never raw counts), sample distance heatmaps, top-DE-gene heatmaps with the row-scaling trap, dispersion / BCV plot interpretation, p-value histogram diagnostics, plotCounts for individual genes, blind=TRUE vs FALSE rationale, and the n=3 visualization stake. Use when generating DE diagnostic plots, choosing VST vs rlog for visualization, troubleshooting suspicious plot patterns (shifted MA cloud, batch-dominated PCA, anti-conservative p-value histogram), or building a standard QC figure panel.

日本語の概要は準備中です。原文の説明を表示しています。

Query protein-protein and gene interaction databases (STRING, BioGRID, IntAct, SIGNOR, Reactome, HuRI, HuMAP, OmniPath, ConsensusPathDB, DIP). Use when building PPI networks, choosing between physical vs functional vs genetic interactions, signed/directed vs undirected, high-throughput vs curated, picking confidence thresholds, aggregating across resources, or navigating license constraints. Encodes the database decision matrix, STRING v12 channel semantics, OmniPath as meta-database, SIGNOR for signed signaling, and per-resource rate limits.

日本語の概要は準備中です。原文の説明を表示しています。

Runs JACKS (Joint Analysis of CRISPR/Cas9 Knockout Screens; Allen et al 2019 Genome Research) which models per-sgRNA log-fold-change as the product of a treatment-dependent gene-essentiality term and a treatment-independent guide-efficacy term. Covers the Bayesian decomposition math, the hierarchical efficacy prior shared across screens performed with the same library, when JACKS outperforms MAGeCK (multi-screen joint analysis, libraries with broad efficacy variance) and when it does not (single screen, novel libraries with no prior efficacy), library-reuse efficacy transfer, downstream essentiality interpretation, and the 2.5x sample-size reduction enabled by efficacy-aware testing. Use when running multiple screens with the same library, when guide-level noise is suspected to dominate per-gene signal, when reusing published essentiality reference screens for efficacy priors, or when comparing screens performed across cell lines that share library but differ biologically.

日本語の概要は準備中です。原文の説明を表示しています。

Resolve the architecture of focal oncogene amplifications — extrachromosomal DNA (ecDNA), breakage-fusion-bridge (BFB) cycles, homogeneously staining regions (HSR), and linear amplification — from whole-genome sequencing with AmpliconArchitect, the AmpliconSuite pipeline, and AmpliconClassifier. Covers copy-number seed selection, breakpoint-graph reconstruction, balanced-flow optimization, ecDNA classification, and the limits of depth-only amplification calls. Use when a focal amplification needs structural characterization, when distinguishing ecDNA from chromosomal amplification, suspecting ecDNA-driven oncogene amplification or therapy resistance, or selecting copy-number seeds for amplicon reconstruction.

日本語の概要は準備中です。原文の説明を表示しています。

Detect and adjust for horizontal pleiotropy in two-sample Mendelian randomization by distinguishing uncorrelated (UHP) from correlated (CHP) pleiotropy and choosing among Egger, MR-PRESSO, MR-RAPS, CAUSE, LHC-MR, LCV, MR-Clust, MR-Mix, and contamination-mixture methods. Use when validating an MR causal claim, running the STROBE-MR sensitivity battery, suspecting a shared heritable confounder, working under weak-instrument or polygenic-exposure regimes, or reconciling discordant estimates across robust methods.

日本語の概要は準備中です。原文の説明を表示しています。

Prove a language switch translates what the user sees, keeps what they had already typed, and is still in force after a reload. Use when i18n, a locale picker, a language menu or translation files were added or changed, when a string is suspected of staying in the old language or showing a raw translation key, or when a user reports losing their form or their language choice after switching or refreshing.

日本語の概要は準備中です。原文の説明を表示しています。

Use when ANY iOS or macOS build fails, a crash log needs diagnosing, a test run crashes, Xcode misbehaves, or an environment issue blocks work before code is the suspect. Covers build failures, dependency conflicts, simulator diagnostics.

日本語の概要は準備中です。原文の説明を表示しています。